Showing results (171-180 of 199) with videos related to
Sort By:
Pageof 20
Antimicrobial Agents and Chemotherapy|July 15, 2009
Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotypeMarianne Gunell, Mark A Webber, Pirkko Kotilainen, et al.Journal of Bacteriology|May 5, 2009
The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the hostMark A Webber, Andrew M Bailey, Jessica M A Blair, et al.The Journal of Antimicrobial Chemotherapy|September 18, 2009
Exposure of Escherichia coli and Salmonella enterica serovar Typhimurium to triclosan induces a species-specific response, including drug detoxificationAndrew M Bailey, Chrystala Constantinidou, Al Ivens, et al.The Journal of Antimicrobial Chemotherapy|October 14, 2023
Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistanceAlasdair P MacGowan, M L G Attwood, Alan R Noel, et al.Emerging Infectious Diseases|April 8, 2011
Complete sequence and molecular epidemiology of IncK epidemic plasmid encoding blaCTX-M-14Jennifer L Cottell, Mark A Webber, Nick G Coldham, et al.Mbio|April 26, 2018
Clinically Relevant Plasmid-Host Interactions Indicate that Transcriptional and Not Genomic Modifications Ameliorate Fitness Costs of Klebsiella pneumoniae Carbapenemase-Carrying PlasmidsMichelle M C Buckner, Howard T H Saw, Rachael N Osagie, et al.The Journal of Antimicrobial Chemotherapy|April 20, 2012
Detection and characterization of pCT-like plasmid vectors for blaCTX-M-14 in Escherichia coli isolates from humans, turkeys and cattle in England and WalesM O Stokes, J L Cottell, L J V Piddock, et al.Mbio|June 4, 2020
Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux PumpElizabeth M Grimsey, Chiara Fais, Robert L Marshall, et al.Mbio|July 16, 2020
New Multidrug Efflux Inhibitors for Gram-Negative BacteriaRobert L Marshall, Georgina S Lloyd, Amelia J Lawler, et al.The Lancet. Microbe|February 8, 2026
Microbiological analysis and whole-genome sequencing of Neisseria gonorrhoeae from the microbiological failures in the international, zoliflodacin, phase 3, clinical trial for treatment of uncomplicated urogenital gonorrhoea: a retrospective, genomic, observational studyMagnus Unemo, Daniel Golparian, Varalakshmi Elango, et al.Pageof 20